Farmacy

Jun 14 2017

404 Page #contract #pharma


#pharma company # Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling. Slide Deck: Kinetic: A new approach shaping the future of advisory boards How many times have we attended meetings that have little direction, or no clear objectives and left feeling disinterested and disengaged? Our “Kinetic” consulting approach is set to change all. Alzheimer’s disease: reviewing the immediate treatment horizon Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer’s disease. Anthill …

Jun 14 2017

The world – s largest pharmaceutical market access conference #pharmaceuticals #news


#world pharma # OVER 250 ATTENDEES 16 COUNTRIES REPRESENTED Great networking, very useful to hear from a mix of pharma companies and payers about market access and evidence requirements – Novartis Pharma About Pharma Pricing & Market Access Congress “Excellent presenters, their knowledge and enthusiasm meant attendees were well educated” Senior Director, European Physician & Payer Forum Get involved PHARMA PRICING & MARKET ACCESS PAST SPONSORS Your sponsorship opportunity SAMPLE OF WHO ATTENDS “Interesting speakers- useful updates on key topics, some thought provoking perspectives-Director, A Connect PAST KEYNOTE SPEAKERS

Jun 14 2017

A – Z Pharmaceutical, Inc #verona #pharma


#drug manufacturer # A Z Pharmaceutical, Inc. Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page …

Jun 14 2017

Sanofi-Aventis U #european #pharmaceutical #companies


#drug manufacturer # Sanofi-Aventis U.S. LLC Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page helpful? …

Jun 14 2017

Intelligent Pharma #am #pharma


#pharma software # Intelligent Pharma is awarded with the Premio Caracter Empresa to Innovation in CatalunyaBarcelona, Spain, 9 th May, 2016 Intelligent Pharma has been recognized once more for its innovation capacity by CaixaBank . the Spanish Confederation of Business Organizations (CEOE), and Foment del Treball . The Innovation category of the Premio Caracter Empresa awards recognizes the best companies with outstanding projects, competitive advantages, and growth potential. Intelligent Pharma, from its headquarters at the PCB, has developed 10 leading technologies in computational chemistry. For us, this award represents an important recognition for our day-to-day work. At Intelligent Pharma, we …

Jun 14 2017

Cooper Pharma Limited #pharmaceutical #industry #marketing


#pharmaceutical manufacturing companies # Manufacturing and providing the best generic medicines, as well as the latest pharmaceutical formulations Offering high-quality pharma products across the globe Employing modern technology for formulation development and manufacturing WE ARE OFFERING 500 latest products and many more Dedicated units for the production of various medicines, Expertise in a Wide Range of Pharma Services More than 60% of total turnover from international operations and an impressive growth of 30% YoY, Exporting of products to more than 25 countries across the globe, Highly experienced and dedicated team of pharma professionals, technocrats, manufacturing and analytical chemists COOPER PHARMA …

Jun 14 2017

Pharmaceutical Manufacturing Company #pharma #consultant


#pharmaceutical manufacturing companies # Company Profile Dalton Pharma Services is a leading cGMP contract service provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries. We are experts in medicinal chemistry, process development and reaction optimization, as well as formulation development, analytical testing and development, cGMP API production and sterile fill-finish services. Dalton brings more than 25 years of experience to every customer project, at virtually any stage. We Discover, Develop and Manufacture. Sector: Pharmaceutical Dosage Form Manufacturing, Active Pharmaceutical Ingredient Manufacturing Fine Chemical Manufacturing. Development Services, Research Services, and Biotechnology. Mission: To benefit the …

Jun 14 2017

Clinical Data Completes Acquisition of Avalon Pharmaceuticals #mds #pharma #services


#avalon pharma # Clinical Data Completes Acquisition of Avalon Pharmaceuticals May 28, 2009 04:06 PM Eastern Daylight Time NEWTON, Mass.–( BUSINESS WIRE )–Clinical Data, Inc. (Nasdaq: CLDA) today announced the completion of its acquisition of Avalon Pharmaceuticals, Inc. Clinical Data acquired Avalon through an all-stock transaction valued at approximately $10 million, based upon the 15-day volume weighted average price of $12.49 for Clinical Data s common stock through Monday, October 27, 2008, the date of the definitive merger agreement. As a result of the acquisition, the common stock of Avalon ceased trading at market close on May 28, 2009. As …

Jun 14 2017

Pharmaceutical Manufacturing #pharmaceutical #research


#pharmaceutical manufacturing # Pharmaceutical Manufacturing About Nowchem Pharma Nowchem Pharma – leading the way in Pharmaceutical Contract Manufacturing Nowra Chemicals diversified into the area of Therapeutic Goods manufacturing and in April 2003 were issued with a TGA licence. Our TGA licence covers products such as head lice preparations, alcohol gels, sunscreens, disinfectants and other topical liquids. All of our Nowchem Pharma production staff have completed training in the good manufacturing code of practice. This ensures our customers receive the agreed standards and practices for the manufacture of their therapeutic goods. The Manufacturing Facility The manufacturing facility currently contains 5 mixing …

Jun 14 2017

Pharmaceutical – Healthcare Market Research #valeo #pharma


#pharma marketing research # MAXimum Research, Inc. – Your Market Research Professionals Here at MAXimum Research, we can reach those doctors others find hard or impossible to reach. Pharma We currently have a medical database containing over one million healthcare professionals, made up of hospitals, MCOs, nurses, and physicians. Our medical interviewers are Elite Interviewers who have at least one year of experience with a background in Pharma. They are trained on recruiting and/or interviewing all types of healthcare workers, from Medical and Pharmacy Directors to nurses and lab technicians, as well as patients with specific ailments, their caretakers, and …